The rise of GLP-1s have made treating obesity one of the largest market opportunities in history. It also has reinforced a ...
Teva is the latest drugmaker to file suit against Medicare negotiations. But unlike other companies that have challenged the ...
HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its ...
After seeing its Covid-19 drug fail in a Phase 3 trial last year, Shionogi on Thursday won a $375 million award from HHS to ...
Most clinical trials for Huntington’s disease have run aground in the last few years, but academic researchers haven’t been ...
UnitedHealth CEO Witty addresses healthcare issues post Brian Thompson's killing, emphasizes existing solutions and defends ...
Novartis is the latest drugmaker to sue the government for allegedly rejecting its proposed model to distribute federal drug ...
Novartis won a potentially short-lived victory in its fight across multiple courts to keep generic versions of its ...
Studies show telemedicine increased therapy access 30% during pandemic, but mainly benefited wealthy, white, urban patients ...
It’s time for one last look at the biotech numbers for 2024. And you might be surprised by some bullish charts below — ...
US regulators have rejected a T cell therapy for a rare and serious transplant complication related to Epstein-Barr virus ...
Vaccine tech company Micron Biomedical has started 2025 on a positive note, raising over $16 million in a Series A extension round. The funding will be used to manufacture its ...